Search

Helpdesk

Sales contact

Home > Resources > Why you should implement a BYOD strategy for your eCOA trial

Why you should implement a BYOD strategy for your eCOA trial

Last updated: May 5, 2025

Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial!

Follow us on social media

Subscribe to our newsletter

You may also like

ePRO in early phase oncology trials: A revolution on the...

Patient-Reported Outcomes in early-phase oncology clinical trialsA Stepping Stone to...

Answering the Sustainability Call: Digital Health Technologies and eCOA

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant...

Engage patients throughout the clinical trial journey

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

PCMG AI Symposium 2025

NOV 24, 2025 • London, UK

PCMG AI Symposium 2025